Cargando…
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design
Autores principales: | Moghnieh, Rima, Abdallah, Dania, Sayegh, Mohamed H., Rahman Bizri, Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212710/ https://www.ncbi.nlm.nih.gov/pubmed/35717109 http://dx.doi.org/10.1016/j.vaccine.2022.04.072 |
Ejemplares similares
-
Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants
por: Moghnieh, Rima, et al.
Publicado: (2022) -
COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be Prepared
por: Moghnieh, Rima, et al.
Publicado: (2020) -
Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022) -
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon
por: Moghnieh, Rima, et al.
Publicado: (2021) -
Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)